Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of
Amryt Pharma Plc

Parma Italy, Dublin Ireland and Boston MA, April 12, 2023 – Chiesi Farmaceutici S.p.A. (“Chiesi”), an international, research-focused biopharmaceuticals and healthcare group, today announced the completion of the acquisition of Amryt Pharma Plc (“Amryt”) (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing, and commercializing novel treatments for rare diseases.